Search Patents
  • Patent number: 9408366
    Abstract: A milking device includes a vessel and cover plate. The vessel and the cover plate form a sealed volume that is internally divided into a collecting chamber, a vacuum chamber and an air intake chamber. The collecting chamber is arranged between the vacuum chamber and the air intake chamber. The vessel has a first internal wall that separates the collecting chamber from the air intake chamber, with a first passage between the collecting chamber and the air intake chamber arranged at the first internal wall. The vessel has a second internal wall that separates the collecting chamber from the vacuum chamber, with a second passage between the collecting chamber and the vacuum chamber arranged at the second internal wall.
    Type: Grant
    Filed: January 19, 2012
    Date of Patent: August 9, 2016
    Assignee: PHARMING INTELLECTUAL PROPERTY BV
    Inventors: Mourad Salaheddine, Marc Peter Elvira Maria Klyutmans, Pieter Cornelis Johannes Maria Streng
  • Publication number: 20230038466
    Abstract: A method for providing a software based secure, robust, flexible, usable, and auditable single method that can practically eliminate threat occurring from phishing, man-in-middle theft, pharming/channel redirection, piggybacking of spyware, and application modification in client applications. These can be very strongly achieved using dynamic virtualization technology. This virtualization technology entirely protects applications from such threats is by creating highly dynamic virtual images of real data that are private, relative, one-time use, and short-lived. These virtual images are strongly made private and relative by creating virtual device id of the client device, virtual application signature of the client application, virtual private network of the network and virtual certificate of the server.
    Type: Application
    Filed: August 9, 2021
    Publication date: February 9, 2023
    Inventor: SURENDRA KUMAR TULSYAN
  • Publication number: 20140373786
    Abstract: A milking device includes a vessel and cover plate. The vessel and the cover plate form a sealed volume that is internally divided into a collecting chamber, a vacuum chamber and an air intake chamber. The collecting chamber is arranged between the vacuum chamber and the air intake chamber. The vessel has a first internal wall that separates the collecting chamber from the air intake chamber, with a first passage between the collecting chamber and the air intake chamber arranged at the first internal wall. The vessel has a second internal wall that separates the collecting chamber from the vacuum chamber, with a second passage between the collecting chamber and the vacuum chamber arranged at the second internal wall.
    Type: Application
    Filed: January 19, 2012
    Publication date: December 25, 2014
    Applicant: Pharming Intellectual Property BV
    Inventors: Mourad Salaheddine, Marc Peter Elvira Maria Kluytmans, Pieter Cornelis Johannes Maria Streng
  • Publication number: 20090089426
    Abstract: The present invention provides a technique of preventing a user from being tricked into revealing personal information by pharming. Security server 50 checks whether a combination of a domain name and an IP address of WWW site 30 to be accessed by PC 10 is registered in access-permit DB 55a or access-inhibit DB 55b. Security sever 50 also checks whether the combination is registered in any of secure DNS servers 40 registered in secure DNS DB 55c. On the basis of a result of the checks, security server 50 controls an access by PC 10 to WWW site 30.
    Type: Application
    Filed: September 28, 2006
    Publication date: April 2, 2009
    Applicant: TREND MICRO INCORPORATED
    Inventors: Yuji Yamasaki, Samuel Pu, Pender Chang, Andrew Lee, Descartes Chen, Jill Yang, Charles Yu, Vincent Chen, Jayce Chang
  • Publication number: 20090055928
    Abstract: Provided is an Internet information security technique, and more particularly, a method for alerting a user that a connected web site is a phishing site by comparing connected web site information with normal site information. To this end, the method includes the steps of: (a) extracting information on a presently connected site; (b) if information on a normal site having the same domain as the connected site exists in a database, comparing the connected site information with the normal site information; and (c) if the connected site information does not match the normal site information, alerting a user that the connected site is a phishing site. Therefore, the user may safely use the Internet by confirming whether the connected web site is a phishing site.
    Type: Application
    Filed: March 27, 2008
    Publication date: February 26, 2009
    Inventors: Jung Min KANG, Do Hoon LEE, Eng Ki PARK, Choon Sik PARK
  • Publication number: 20070185011
    Abstract: The present invention relates to the use of a C1 inhibitor (C1INH) with shorter half-life than plasma-derived C1INH for the preparation of a medicament for the transient treatment of an individual. It relates to both therapeutic and prophylactic treatment. The method of the invention allows for the administration of C1INH at certain therapeutic levels for a concise pre-determined time span. Pharmaceutical compositions based on C1INH with shorter half-lives may be used both in situations where transient treatment is merely and advantage. The advantage of the use according to the invention is that an individual is not exposed to C1INH for longer than required, since the levels of the C1INH more rapidly subsides after administration has stopped. In contrast, levels of plasma-derived C1INH would remain elevated for a prolonged period of time.
    Type: Application
    Filed: May 14, 2004
    Publication date: August 9, 2007
    Applicant: Pharming Intellectual Property B.V.
    Inventor: Johannes Nuijens
  • Patent number: 8195816
    Abstract: The present invention provides a technique of preventing a user from being tricked into revealing personal information by pharming. Security server 50 checks whether a combination of a domain name and an IP address of WWW site 30 to be accessed by PC 10 is registered in access-permit DB 55a or access-inhibit DB 55b. Security sever 50 also checks whether the combination is registered in any of secure DNS servers 40 registered in secure DNS DB 55c. On the basis of a result of the checks, security server 50 controls an access by PC 10 to WWW site 30.
    Type: Grant
    Filed: September 28, 2006
    Date of Patent: June 5, 2012
    Assignee: Trend Micro Incorporated
    Inventors: Yuji Yamasaki, Samuel Pu, Pender Chang, Andrew Lee, Descartes Chen, Jill Yang, Charles Yu, Vincent Chen, Jayce Chang
  • Patent number: 7544853
    Abstract: The present invention relates to the use of a C1 inhibitor (C1INH) with shorter half-life than plasma-derived C1INH for the preparation of a medicament for the transient treatment of an individual. It relates to both therapeutic and prophylactic treatment. The method of the invention allows for the administration of C1INH at certain therapeutic levels for a concise pre-determined time span. Pharmaceutical compositions based on C1INH with shorter half-lives may be used both in situations where transient treatment is merely and advantage. The advantage of the use according to the invention is that an individual is not exposed to C1INH for longer than required, since the levels of the C1INH more rapidly subsides after administration has stopped. In contrast, levels of plasma-derived C1INH would remain elevated for a prolonged period of time.
    Type: Grant
    Filed: May 14, 2004
    Date of Patent: June 9, 2009
    Assignee: Pharming Intellectual Property B.V.
    Inventor: Johannes Henricus Nuijens
  • Publication number: 20080028444
    Abstract: A secure authentication process detects and prevents phishing and pharming attacks for specific web sites. The process is based on a dedicated secure hardware store for user sign-in credentials, a database of information about specific web sites, and a private secure browser. All user web activity is monitored by an agent program. The agent program checks to make sure that user attempts to send any sign-in credentials stored in secure hardware store of user sign-in credentials, to any web site accessed by the user, is allowed only if the IP address of the web site accessed by the user matches at least one of the IP addresses stored web site database associated with the sign-in credential the user is attempting to send. The process also detects mismatches between a URL and the actual IP address of the web site associated with the URL.
    Type: Application
    Filed: July 27, 2007
    Publication date: January 31, 2008
    Inventors: William Loesch, Derek Fluker
  • Patent number: 8316440
    Abstract: Detection for pharming attacks and specifically for changes in name-to-IP resolutions on a computer system using rules is described. The DNS settings and the Hosts file on a computer system are monitored and their modification information is saved as a part of the historical data over time. When an IP address is determined for a host name, various rules are applied to the IP address in connection with the saved historical data, such that each rule produces a score based on various criteria. Different rules may have different weights assigned to their scores. The scores of all the rules are summed up to produce a final score. If the final score is above a predefined value, then there is a suspicious change in the IP address, and an alert is sent. Otherwise, the host name and the IP address are saved as a part of the historical data.
    Type: Grant
    Filed: October 30, 2007
    Date of Patent: November 20, 2012
    Assignee: Trend Micro, Inc.
    Inventors: Sheng-Chi Hsieh, Chao-Yu Chen, Chih-Chia Chen
  • Publication number: 20090037997
    Abstract: Certificate information associated with a received certificate, such as a Secure Sockets Layer (SSL) certificate is stored in a trusted local cache and/or in one or more remote trusted sources, such as a single remote trusted source and/or a trusted peer network. When a site certificate is received on a host computer system, certificate information associated with the received site certificate is obtained and compared with the stored certificate information to determine whether or not the site certificate indicates malicious activity, such as a malicious DNS redirection or a fraudulent local certificate. When a site certificate is not found indicative of malicious activity, the site certificate is released. Alternatively, when a site certificates is found indicative of malicious activity protective action is taken. In some embodiments, a user's log-in credentials are automatically obtained from a trusted local cache and automatically submitted to a web site.
    Type: Application
    Filed: July 31, 2007
    Publication date: February 5, 2009
    Inventors: Paul Agbabian, William E. Sobel, Bruce McCorkendale
  • Patent number: 8095967
    Abstract: A secure authentication process detects and prevents phishing and pharming attacks for specific web sites. The process is based on a dedicated secure hardware store for user sign-in credentials, a database of information about specific web sites, and a private secure browser. All user web activity is monitored by an agent program. The agent program checks to make sure that user attempts to send any sign-in credentials stored in secure hardware store of user sign-in credentials, to any web site accessed by the user, is allowed only if the IP address of the web site accessed by the user matches at least one of the IP addresses stored web site database associated with the sign-in credential the user is attempting to send. The process also detects mismatches between a URL and the actual IP address of the web site associated with the URL.
    Type: Grant
    Filed: July 27, 2007
    Date of Patent: January 10, 2012
    Assignee: White Sky, Inc.
    Inventors: William Loesch, Derek Fluker
  • Patent number: 8429734
    Abstract: Certificate information associated with a received certificate, such as a Secure Sockets Layer (SSL) certificate is stored in a trusted local cache and/or in one or more remote trusted sources, such as a single remote trusted source and/or a trusted peer network. When a site certificate is received on a host computer system, certificate information associated with the received site certificate is obtained and compared with the stored certificate information to determine whether or not the site certificate indicates malicious activity, such as a malicious DNS redirection or a fraudulent local certificate. When a site certificate is not found indicative of malicious activity, the site certificate is released. Alternatively, when a site certificates is found indicative of malicious activity protective action is taken. In some embodiments, a user's log-in credentials are automatically obtained from a trusted local cache and automatically submitted to a web site.
    Type: Grant
    Filed: July 31, 2007
    Date of Patent: April 23, 2013
    Assignee: Symantec Corporation
    Inventors: Paul Agbabian, William E. Sobel, Bruce McCorkendale
  • Patent number: 6066725
    Abstract: Transgenes for producing recombinant polypeptides transgenic bovine species are described. A transgene for producing recombinant polypeptides in the milk of transgenic bovine species comprises at least one expression regulation sequence, a secretory DNA sequence encoding a secretory signal sequence which is functional in mammary secretory cells of the bovine species and a recombinant DNA sequence encoding the recombinant polypeptide. Also included are methods for producing transgenic bovine species. The method includes introducing the above transgene into an embryonal target cell of a bovine species, transplanting the transgenic embryonic target cell formed thereby into a recipient bovine parent and identifying at least one female offspring which is capable of producing the recombinant polypeptide in its milk.
    Type: Grant
    Filed: September 21, 1998
    Date of Patent: May 23, 2000
    Assignee: Pharming B.V.
    Inventors: Herman A. DeBoer, Rein Strijker, Herbert L. Heyneker, Gerard Platenburg, Sang He Lee, Frank Pieper, Paul J. A. Krimpenfort
  • Publication number: 20070220594
    Abstract: A software based method and system providing secure and robust multifactor authentication of internet users using at least one factor each of 1) Something you know; 2) Something you have; and 3) Something you are—A physical characteristic of the user or his/her computer/device. This method of authenticating the identity of a user to determine access to a host includes providing an encrypted key string based on one or more static and dynamic factors corresponding the data instances of a user or his/her computer/device, one or more static and dynamic factors corresponding the data instances of the host, and user input factors; evaluating the factor-based data instances to determine if the user's identity is authenticated; and granting or restricting the user's access to the host based on authentication results. The provider generates a key string based on the inputs gathered/provided, time stamps the key, encrypts the key and sends it to the host.
    Type: Application
    Filed: March 4, 2006
    Publication date: September 20, 2007
    Inventor: Surendra Tulsyan
  • Publication number: 20050198698
    Abstract: Transgenes for producing recombinant polypeptides transgenic bovine species. A transgene for producing recombinant polypeptides in the milk of transgenic bovine species comprises at least one expression regulation sequence, a secretory DNA sequence encoding a secretory signal sequence which is functional in mammary secretory cells of the bovine species and a recombinant DNA sequence encoding the recombinant polypeptide. Also included are methods for producing transgenic bovine species. The method includes introducing the above transgene into an embryonal target cell of a bovine species, transplanting the transgenic embryonic target cell formed thereby into a recipient bovine parent and identifying at least one female offspring which is capable of producing the recombinant polypeptide in its milk.
    Type: Application
    Filed: November 12, 2004
    Publication date: September 8, 2005
    Applicant: Pharming B.V., a Netherlands corporation
    Inventors: Herman DeBoer, Rein Strijker, Herbert Heyneker, Gerard Plantenburg, Sang Lee, Frank Pieper, Paul Krimpenfort
  • Publication number: 20030192068
    Abstract: Transgenes for producing recombinant polypeptides transgenic bovine species. A transgene for producing recombinant polypeptides in the milk of transgenic bovine species comprises at least one expression regulation sequence, a secretory DNA sequence encoding a secretory signal sequence which is functional in mammary secretory cells of the bovine species and a recombinant DNA sequence encoding the recombinant polypeptide. Also included are methods for producing transgenic bovine species. The method includes introducing the above transgene into an embryonal target cell of a bovine species, transplanting the transgenic embryonic target cell formed thereby into a recipient bovine parent and identifying at least one female offspring which is capable of producing the recombinant polypeptide in its milk.
    Type: Application
    Filed: June 11, 2002
    Publication date: October 9, 2003
    Applicant: Pharming B.V.
    Inventors: Herman A. DeBoer, Rein Strijker, Herbert L. Heynecker, Gerard Platenburg, Sang Ha Lee, Frank Pieper, Paul J.A. Krimpenfort
  • Patent number: 6140552
    Abstract: Transgenes for producing recombinant polypeptides transgenic bovine species. A transgene for producing recombinant polypeptides in the milk of transgenic bovine species comprises at least one expression regulation sequence, a secretory DNA sequence encoding a secretory signal sequence which is functional in mammary secretory cells of the bovine species and a recombinant DNA sequence encoding the recombinant polypeptide. Also included are methods for producing transgenic bovine species. The method includes introducing the above transgene into an embryonal target cell of a bovine species, transplanting the transgenic embryonic target cell formed thereby into a recipient bovine parent and identifying at least one female offspring which is capable of producing the recombinant polypeptide in its milk.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: October 31, 2000
    Assignee: Pharming B.V.
    Inventors: Herman A. Deboer, Rein Strijker, Herbert L. Heyneker, Gerard Platenburg, Sang He Lee, Frank Pieper, Paul J. A. Krimpenfort
  • Patent number: 6013857
    Abstract: Transgenes for producing recombinant polypeptides transgenic bovine species. A transgene for producing recombinant polypeptides in the milk of transgenic bovine species comprises at least one expression regulation sequence, a secretory DNA sequence encoding a secretory signal sequence which is functional in mammary secretory cells of the bovine species and a recombinant DNA sequence encoding the recombinant polypeptide. Also included are methods for producing transgenic bovine species. The method includes introducing the above transgene into an embryonal target cell of a bovine species, transplanting the transgenic embryonic target cell formed thereby into a recipient bovine parent and identifying at least one female offspring which is capable of producing the recombinant polypeptide in its milk.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: January 11, 2000
    Assignee: Pharming B.V.
    Inventors: Herman A. Deboer, Rein Strijker, Herbert L. Heyneker, Gerard Platenburg, Sang He Lee, Frank Pieper, Paul J. A. Krimpenfort
  • Patent number: RE43691
    Abstract: The present invention relates to the use of a C1 inhibitor (C1INH) with shorter half-life than plasma-derived C1INH for the preparation of a medicament for the transient treatment of an individual. It relates to both therapeutic and prophylactic treatment. The method of the invention allows for the administration of C1INH at certain therapeutic levels for a concise pre-determined time span. Pharmaceutical compositions based on C1INH with shorter half-lives may be used both in situations where transient treatment is merely and advantage. The advantage of the use according to the invention is that an individual is not exposed to C1INH for longer than required, since the levels of the C1INH more rapidly subsides after administration has stopped. In contrast, levels of plasma-derived C1INH would remain elevated for a prolonged period of time.
    Type: Grant
    Filed: May 14, 2004
    Date of Patent: September 25, 2012
    Assignee: Pharming Intellectual Property B.V.
    Inventor: Johannes Henricus Nuijens
Narrow Results

Filter by US Classification